A recent study indicates that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle programs.
Published data in a major health publication shows that while obese individuals often shed about a fifth of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing such treatments need to be aware of the potential of rapid weight regain when the medication ends," warns researcher Dr. Susan Jebb.
This pace of recovery means a reversion to original weight within about a year and a half.
Comparing Treatments
The analysis, which reviewed 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.
Scientists point out that people who shed pounds through diet and exercise usually experience a less rapid weight regain—approximately 100 grams monthly—after stopping.
Understanding the Fast Rebound
Experts propose the mode of action of the jabs is key to understanding the heightened regain.
The injections copy a body's own chemical called GLP-1, which moderates feelings of fullness.
"Long-term administration of the hormone levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication leads to hunger is no longer kept in check, making binge eating far more likely."
A Lifelong Disease?
Health authorities advise the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians contend that, due to the high risk of relapse, the therapy should be considered long-term.
This perspective is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have discontinued the jabs report a sudden resurgence of hunger.
"It was like a switch flipping and you're instantly ravenous," said one woman.
The struggle is compounded if patients have not established lasting dietary or behavioural changes during therapy.
Significant Use
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is more common among females compared to men.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Ultimately, clinicians stress that while these medications are potent tools for weight loss, they are not a standalone cure and lasting health benefits hinges on integrated lifestyle support.
